Chemical Identity and Structural Features

Ditert-butyl 2-(2-methoxy-2-oxo-ethyl)piperazine-1,4-dicarboxylate (Aladdin SKU: D638230) is a piperazine-based compound in which both ring nitrogen atoms are protected as tert-butyloxycarbonyl (Boc) carbamates. A methylene acetic acid methyl ester (–CH₂CO₂CH₃) substituent is present at the C-2 position of the piperazine ring, introducing a stereocenter and a reactive ester handle.

The dual Boc protection renders the two piperazine nitrogens orthogonally deprotectable under standard acidic conditions (e.g., trifluoroacetic acid or HCl in dioxane), while the methyl ester can be selectively hydrolyzed, reduced, or otherwise transformed under mild conditions. This combination of protecting groups provides synthetic flexibility during multi-step drug synthesis.

The compound belongs to the broader class of N,N'-di-Boc piperazine building blocks that are essential in modern medicinal chemistry for constructing libraries of drug-like molecules.

Synthetic Applications and Reactivity

As a bifunctional building block, ditert-butyl 2-(2-methoxy-2-oxo-ethyl)piperazine-1,4-dicarboxylate offers multiple sites for chemical manipulation, making it valuable in pharmaceutical intermediate synthesis:

• Boc deprotection: Treatment with trifluoroacetic acid (TFA) in dichloromethane or 4 M HCl in 1,4-dioxane selectively removes one or both Boc groups to reveal free secondary amine(s) for further functionalization such as amide coupling, reductive amination, or N-alkylation.
• Ester hydrolysis: The methyl ester can be saponified under basic aqueous conditions (e.g., LiOH or NaOH in THF/water) to yield the corresponding acetic acid derivative, which can then be activated for amide bond formation.
• Ester reduction: Selective reduction with reagents such as LiAlH₄ or DIBAL-H converts the methyl ester to the primary alcohol, expanding access to hydroxymethyl-functionalized piperazine scaffolds.
• Fragment coupling: The free acid (after hydrolysis) or activated ester can be coupled with amines via standard peptide coupling protocols (e.g., HATU, EDC/HOBt) to introduce amide-containing pharmacophores.

These reaction pathways make the compound a key intermediate for generating structurally diverse piperazine-containing drug candidates in hit-to-lead and lead optimization campaigns.

Handling, Storage, and Safety Guidelines

Researchers working with ditert-butyl 2-(2-methoxy-2-oxo-ethyl)piperazine-1,4-dicarboxylate (D638230) should observe standard laboratory safety practices for fine organic chemicals:

Personal Protective Equipment (PPE)

• Wear chemical-resistant gloves (nitrile recommended), a laboratory coat, and safety spectacles or goggles at all times when handling the compound.
• Perform all weighing and solution preparation inside a well-ventilated fume hood to minimize inhalation of dust or vapors.

Storage Conditions

• Store in a tightly sealed container in a cool (typically 2–8 °C or as specified on the product label), dry location away from direct light.
• Keep away from strong oxidizing agents, strong acids, and strong bases to avoid decomposition of the Boc groups or the ester functionality.
• Check the supplier-provided Safety Data Sheet (SDS) for compound-specific hazard classifications and first-aid measures before use.

Waste Disposal

• Dispose of waste material and contaminated solvents in accordance with local, institutional, and governmental regulations for organic chemical waste.

Note: Specific GHS hazard classifications for D638230 should be confirmed against the current Aladdin SDS prior to use.

Quality, Purity, and Analytical Verification

For reliable results in sensitive synthetic applications, researchers should verify the identity and purity of ditert-butyl 2-(2-methoxy-2-oxo-ethyl)piperazine-1,4-dicarboxylate upon receipt and before use:

• NMR Spectroscopy: ¹H NMR and ¹³C NMR in deuterated solvents (e.g., CDCl₃ or DMSO-d₆) are the primary tools for confirming molecular structure, Boc group integrity (typically observed as singlets near δ 1.4 ppm for the tert-butyl protons), and ester methyl resonance (typically near δ 3.7 ppm).
• HPLC Purity: Reverse-phase HPLC (C18 column, UV detection at 210–220 nm) provides a quantitative purity assessment. Purity ≥95% is generally recommended for use in medicinal chemistry synthesis.
• Mass Spectrometry: ESI-MS or APCI-MS confirms the molecular ion consistent with the expected molecular formula. Common adducts include [M+H]⁺, [M+Na]⁺, and [M+NH₄]⁺.
• TLC: Thin-layer chromatography can be used as a rapid in-lab check of compound identity and homogeneity using appropriate eluent systems (e.g., ethyl acetate/hexane mixtures).

Contact Aladdin Scientific technical support if the analytical data supplied with the Certificate of Analysis (CoA) requires clarification or if out-of-specification results are observed.